• German
German

Main Navigation

Alexander Schramm and Sven Rahmann from project C1 investigate the impact of telomeres on neuroblastoma

December 20, 2018 14:17


Neuroblastomas—the most common tumor type in infants—develop from fetal nerve cells, and their clinical course is highly variable. Some neuroblastomas are fatal despite treatment, whereas others respond well to treatment and some undergo spontaneous regression without treatment. Ackermann et al. sequenced more than 400 pretreatment neuroblastomas and identified molecular features that characterize the three distinct clinical outcomes. Low-risk tumors lack telomere maintenance mechanisms, intermediate-risk tumors harbor telomere maintenance mechanisms, and high-risk tumors harbor telomere maintenance mechanisms in combination with RAS and/or p53 pathway mutations. 

 



http://science.sciencemag.org/content/362/6419/1165

SFB-876 NEWSLETTER
Newsletter RSS Twitter

NEWEST TECHREPORTS